Related Experiment Videos

A novel amyloid fibril protein isolated from senescence-accelerated mice

Insights

Researchers isolated a novel amyloid protein, ASSAM, from the livers of aging mice with systemic amyloidosis. This protein is distinct from known murine amyloid proteins and immunoglobulins.

Area of Science:

  • Biochemistry
  • Immunology
  • Gerontology

Background:

  • Systemic amyloidosis is common in senescence-accelerated mice.
  • Amyloid protein characterization is crucial for understanding age-associated diseases.
  • Previous murine amyloid protein studies focused on specific strains.

Purpose of the Study:

  • To isolate and characterize a novel amyloid protein from senescence-accelerated mice.
  • To determine if this protein is related to known murine amyloid proteins or immunoglobulins.
  • To investigate potential links to human amyloidosis.

Main Methods:

  • Protein isolation from liver amyloid fibrils.
  • Electrophoretic mobility analysis.
  • Amino acid composition and sequence analysis.
  • Immunochemical assays using antisera.

Main Results:

  • A 5200-dalton protein, designated ASSAM, was isolated.
  • ASSAM exhibits different electrophoretic mobility and amino acid composition compared to murine protein AA.
  • Sequence analysis revealed a blocked N-terminus.
  • ASSAM showed no cross-reactivity with murine protein AA, immunoglobulins, or normal liver proteins.

Conclusions:

  • ASSAM is a novel amyloid protein distinct from previously identified murine amyloid proteins.
  • ASSAM is not related to immunoglobulins.
  • Further research is needed to explore ASSAM's relationship with human senile cardiac amyloidosis (ASc).

Related Concept Videos